Costly Rare Cancer Drugs Fund Fails to Provide Clinical Benefit

Set up to improve access to anti-cancer orphan drugs, the CDF did not live up to its promise, says Dr Kerr.

Source: Medscape Oncology - January 30, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts